Pass the ACT for ALS Reauthorization Act to reauthorize ACT for ALS programs for five years, codify HHS eligibility guidance, require a new FDA five-year action plan, and require a GAO report on implementation.

It’s now critical that Congress builds upon that milestone by passing the ACT for ALS Reauthorization Act to continue our progress in researching cures and treatments.

Calvert commits to passing the ALS reauthorization bill that would extend programs and add oversight and implementation requirements.

Calvert, Quigley Introduce Bill To Advance ALS Research and Keep Treatments Available | Congressman Ken Calvert
primary · press_release · model gpt-5.4-mini

Action: Mr. Quigley (for himself and Mr. Calvert) introduced the following bill; which was referred to the Committee on Energy and Commerce. Full title: To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.

The bill was formally introduced and referred to committee, matching the requested reauthorization framework but not yet enacted.

unresolved same_term A for effort

H.R. 8205 (IH) - Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 - GovInfo
secondary · model gpt-5.4-mini · confidence 98%

Items to be considered include H.R. 8205, Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 (Reps. Quigley and Calvert). The notice sets a Subcommittee on Health markup for Wednesday, May 13, 2026.

The House Energy and Commerce leadership scheduled H.R. 8205 for subcommittee markup, a concrete legislative step toward the claim.

partial same_term A for effort

Chairmen Guthrie and Griffith Announce Health Subcommittee Markup of Public Health Reauthorizations and Policies to Improve FDA and Medicare
secondary · model gpt-5.4-mini · confidence 96%

The ALS Association strongly supports the Committee’s consideration of H.R. 8205, the Accelerating Access to Critical Therapies for ALS Reauthorization Act. The statement says recent GAO findings confirm ACT for ALS is advancing coordination and that H.R. 8205 responds directly by clarifying authorities, strengthening oversight, and aligning statutory requirements with scientific realities.

A formal record for the subcommittee markup shows the bill was actively considered and supported, but this does not by itself show final committee passage.

partial same_term A for effort

Documents for the Record: Statement for the Record from The ALS Association on H.R. 8205
secondary · model gpt-5.4-mini · confidence 93%

The full committee markup agenda lists H.R. 8205, Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026, among the bills under consideration. The page shows amendments added for H.R. 8205 and lists the markup as occurring on Thursday, May 21, 2026.

As of the lookback endpoint, the bill had advanced to full committee markup but there is no official evidence here of final committee reporting or House passage.

unresolved same_term A for effort

Full Committee Markup of 16 Bills | Committee Repository
secondary · model gpt-5.4-mini · confidence 91%